Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kythera Biopharmaceuticals nets $75.3mm through its IPO

Executive Summary

Aesthetic and medical dermatology company Kythera Biopharmaceuticals Inc. has netted $75.3mm through its initial public offering of 5.1mm common shares (including the overallotment) at $16, the top of its proposed pricing ($14-16 announced last month).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies